Narendra D. Lalwani
About
Narendra D. Lalwani is a scholar working on Molecular Biology, Cancer Research and Surgery.
According to data from OpenAlex, Narendra D. Lalwani has authored 65 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Narendra D. Lalwani's work include Peroxisome Proliferator-Activated Receptors (31 papers), Metabolism and Genetic Disorders (11 papers) and Lipoproteins and Cardiovascular Health (11 papers). Narendra D. Lalwani is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (31 papers), Metabolism and Genetic Disorders (11 papers) and Lipoproteins and Cardiovascular Health (11 papers). Narendra D. Lalwani collaborates with scholars based in United States, Canada and Japan. Narendra D. Lalwani's co-authors include Janardan K. Reddy, M. K. Reddy, Lulu Ren Sterling, Saeed A. Qureshi, Christie M. Ballantyne, Paula Robinson, LeAnne T. Bloedon, Alberico L. Catapano, Harold Bays and Kausik K. Ray and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.
In The Last Decade
Narendra D. Lalwani
64 papers receiving 3.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Narendra D. Lalwani United States | 30 | 2.2k | 1.4k | 788 | 630 | 620 | 65 | 4.1k | ||
| Keith E. Suckling United Kingdom | 29 | 1.6k 0.7× | 2.1k 1.5× | 779 1.0× | 457 0.7× | 731 1.2× | 123 | 4.1k | ||
| Patrick I. Eacho United States | 28 | 1.3k 0.6× | 1.1k 0.8× | 436 0.6× | 567 0.9× | 519 0.8× | 61 | 2.7k | ||
| Ganesamoorthy Subbanagounder United States | 27 | 1.8k 0.8× | 1.3k 0.9× | 324 0.4× | 202 0.3× | 714 1.2× | 29 | 5.2k | ||
| D K Spady United States | 37 | 1.4k 0.6× | 2.8k 2.0× | 685 0.9× | 887 1.4× | 819 1.3× | 53 | 4.4k | ||
| C L Bisgaier United States | 25 | 906 0.4× | 1.3k 0.9× | 535 0.7× | 196 0.3× | 1.1k 1.8× | 37 | 3.2k | ||
| Carl P. Sparrow United States | 29 | 2.0k 0.9× | 2.1k 1.5× | 498 0.6× | 730 1.2× | 478 0.8× | 48 | 4.4k | ||
| Guy Chisolm United States | 36 | 1.4k 0.7× | 1.2k 0.9× | 316 0.4× | 213 0.3× | 530 0.9× | 56 | 4.8k | ||
| Philippe Costet France | 32 | 2.1k 1.0× | 3.2k 2.3× | 644 0.8× | 1.1k 1.7× | 631 1.0× | 45 | 4.5k | ||
| R C Pittman United States | 25 | 1.3k 0.6× | 2.1k 1.5× | 781 1.0× | 422 0.7× | 1.1k 1.9× | 32 | 3.8k | ||
| Tracey Smith-Oliver United States | 13 | 3.5k 1.6× | 1.1k 0.8× | 760 1.0× | 833 1.3× | 460 0.7× | 14 | 4.7k |
Countries citing papers authored by Narendra D. Lalwani
Since
Specialization
Citations
This map shows the geographic impact of Narendra D. Lalwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narendra D. Lalwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narendra D. Lalwani more than expected).
Fields of papers citing papers by Narendra D. Lalwani
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Narendra D. Lalwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narendra D. Lalwani. The network helps show where Narendra D. Lalwani may publish in the future.
Co-authorship network of co-authors of Narendra D. Lalwani
This figure shows the co-authorship network connecting the top 25 collaborators of Narendra D. Lalwani. A scholar is included among the top collaborators of Narendra D. Lalwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narendra D. Lalwani. Narendra D. Lalwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lalwani, Narendra D., Jeffrey C. Hanselman, Diane MacDougall, Lulu Ren Sterling, & Clay T. Cramer. (2019). Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial. Journal of clinical lipidology. 13(4). 568–579.
2.
Ballantyne, Christie M., James M. McKenney, Diane MacDougall, et al.. (2016). Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy. The American Journal of Cardiology. 117(12). 1928–1933.
3.
Pinkosky, Stephen L., et al.. (2015). Abstract 17608: Identification of a Tissue-specific Very Long-chain Acyl-CoA Synthetase Involved in the Inhibition of ATP-Citrate Lyase (ACL) by ETC-1002: A Novel Mechanism for Cholesterol Biosynthesis Inhibition in the Liver. Circulation. 132(suppl_3).
4.
Tardy, Claudine, Nadia Boubekeur, Daniela C. Oniciu, et al.. (2014). P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo. PLoS ONE. 9(4). e95807–e95807.
5.
Tardy, Claudine, Nadia Boubekeur, Rose Ackermann, et al.. (2013). CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis. 232(1). 110–118.
6.
Keyserling, Constance, Thomas L. Hunt, Robert A. Scott, et al.. (2011). Abstract 15525: CER-001, a Synthetic HDL-Mimetic, Safely Mobilizes Cholesterol in Healthy Dyslipidemic Volunteers. Circulation. 124.
7.
Bodary, Peter F., Yuechun Shen, Randal J. Westrick, et al.. (2004). 1064-182 Gene transfer of an ApoA-I mimetic peptide reduces atherosclerosis in mice. Journal of the American College of Cardiology. 43(5). A465–A466.
8.
Iglesia, Felix A. de la, Edward J. McGuire, Jeffrey R. Haskins, & Narendra D. Lalwani. (1996). Structural Diversity of Peroxisome Proliferators and Their Effects on Mammalian Liver Cells in Vivo. Annals of the New York Academy of Sciences. 804(1). 310–327.
9.
Sigler, Robert E., et al.. (1995). Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 327(1-2). 151–160.
10.
Robertson, Donald G., et al.. (1995). Changes in Monkey Plasma Purines Induced by Repeated Doses of CI-1000, a Novel Inhibitor of Purine Nucleoside Phosphorylase. Advances in experimental medicine and biology. 370. 173–177.
11.
Baragi, Vijay, David Brott, Luping Qiu, M.C. Conroy, & Narendra D. Lalwani. (1995). Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.. PubMed. 72(4). 484–90.
12.
Krishna, G., et al.. (1995). Simultaneous evaluation of dexamethasone-induced apoptosis and micronuclei in rat primary spleen cell cultures. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 332(1-2). 1–8.
13.
Richardson, Bruce C., Narendra D. Lalwani, Kent J. Johnson, & Rory M. Marks. (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. European Journal of Immunology. 24(11). 2640–2645.
14.
Shamsuddin, Abulkalam M., Abdul Baten, & Narendra D. Lalwani. (1992). Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line. Cancer Letters. 64(3). 195–202.
15.
Lalwani, Narendra D., Philip B. Hylemon, & Stephen C. Strom. (1991). Altered levels of phosphoinositide metabolites and activation of guanine‐nucleotide dependent phospholipase C in rat hepatic tumors. Journal of Cellular Physiology. 147(2). 354–361.
16.
Reddy, Janardan K., M. K. Reddy, M I Usman, Narendra D. Lalwani, & Rao Ms. (1986). Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.. Environmental Health Perspectives. 65. 317–327.
17.
Rao, Mahendra S., Narendra D. Lalwani, Dante G. Scarpelli, & Janardan K. Reddy. (1982). The absence of γglutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643. Carcinogenesis. 3(10). 1231–1233.
18.
Warren, Jim, Narendra D. Lalwani, & Janardan K. Reddy. (1982). Phthalate esters as peroxisome proliferator carcinogens.. Environmental Health Perspectives. 45. 35–40.
19.
Reddy, Janardan K., Narendra D. Lalwani, & Arun S. Dabholkar. (1981). Increased peroxisomal activity in the liver of vitamin E deficient rats. 3(1). 41–49.
20.
Lalwani, Narendra D., et al.. (1980). Effect of Barbiturates on Radiosensitivity of Cells: a Comparative Study of Electrophoretic Mobility, Colony Forming Ability and Thymidine Uptake on Human Amnion Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 37(3). 337–342.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Keith E. Suckling Breakdown of academic impact, for papers by Patrick I. Eacho Breakdown of academic impact, for papers by Ganesamoorthy Subbanagounder Breakdown of academic impact, for papers by D K Spady Breakdown of academic impact, for papers by C L Bisgaier Breakdown of academic impact, for papers by Carl P. Sparrow Breakdown of academic impact, for papers by Guy Chisolm Breakdown of academic impact, for papers by Philippe Costet Breakdown of academic impact, for papers by R C Pittman Breakdown of academic impact, for papers by Tracey Smith-Oliver